Cencora Inc (COR) Stock Price, Quote & News

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management...

Industry: Medical Distribution

Sector: Healthcare

Phone: 610 727 7000

Website: www.cencora.com

Address:

1 West First Avenue, Conshohocken, United States

SweepCastApp Oct. 3 at 3:43 PM

$COR: Unusual Options Activity Alerted CALL flow observed 13x contracts at Strike price of $310 Exp on 01/15/2027 with Premium of $59K and showing NEUTRAL Sentiment

0 · Reply

MoneyGroupLLC Oct. 3 at 1:11 AM

Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $9.20 - $9.80 Take Profit: $13.72 Stop Bleeding: $8.62 ROI Potential: 40% Exit Within: 227 Minutes https://moneygroup.us/alerts

0 · Reply

StockAutoPro Oct. 2 at 5:39 PM

$COR: Buy target $309.19 Sell target $326.74 Expect volatility in COR stocks due to increased competition in the cloud data storage market.

0 · Reply

MoneyGroupLLC Oct. 2 at 7:05 AM

Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $9.80 - $11.00 Take Profit: $23.42 Stop Bleeding: $8.62 ROI Potential: 139% Exit Within: 93 Minutes https://moneygroup.us/alerts

0 · Reply

SweepCastApp Oct. 2 at 5:51 AM

$COR: Unusual Options Activity Alerted CALL flow observed 10x contracts at Strike price of $220 Exp on 10/17/2025 with Premium of $88K and showing BEARISH Sentiment

0 · Reply

MoneyGroupLLC Oct. 1 at 12:05 PM

Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $8.85 - $10.40 Take Profit: $13.89 Stop Bleeding: $7.79 ROI Potential: 57% Exit Within: 365 Minutes https://moneygroup.us/alerts

0 · Reply

MoneyGroupLLC Sep. 30 at 11:43 PM

Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $7.00 - $9.20 Take Profit: $11.13 Stop Bleeding: $6.16 ROI Potential: 59% Exit Within: 372 Minutes https://moneygroup.us/alerts

0 · Reply

highnihilism Sep. 30 at 8:10 AM

$COMM Commscope: 553 trades, $360K vs $920K avg (0.39x). $231K calls / $128K puts. $COR Cencora: 84 trades, $268K vs $656K avg (0.41x). $230K calls / $39K puts. $IDT IDT: 398 trades, $321K vs $14K avg (22.72x 🚨). $229K calls / $92K puts. $BUR Burford Capital: 38 trades, $233K vs $128K avg (1.83x). $229K calls / $4K puts.

0 · Reply

MoneyGroupLLC Sep. 29 at 11:22 PM

Enter: $COR NOV 21 2025 $310 CALLS Buy in Price: $11.05 - $11.60 Take Profit: $21.99 Stop Bleeding: $9.72 ROI Potential: 99% Exit Within: 268 Minutes https://moneygroup.us/alerts

0 · Reply

StockAutoPro Sep. 29 at 9:57 PM

$COR: Buy target $306.07 Sell target $323.47 Recent acquisitions are driving significant growth for this leading waste management company.

0 · Reply

Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 9, 2025, 6:02 PM EDT - 25 days ago

Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 5, 2025, 11:11 AM EDT - 4 weeks ago

Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Aug 27, 2025, 4:15 PM EDT - 5 weeks ago

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Aug 12, 2025, 2:31 PM EDT - 7 weeks ago

Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap

Aug 8, 2025, 5:08 PM EDT - 2 months ago

Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy

Aug 6, 2025, 12:25 PM EDT - 2 months ago

Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript

Aug 6, 2025, 7:51 AM EDT - 2 months ago

Cencora raises annual profit forecast on strong demand for specialty drugs

Aug 6, 2025, 6:30 AM EDT - 2 months ago

Cencora Reports Fiscal 2025 Third Quarter Results

Jul 3, 2025, 7:30 AM EDT - 3 months ago

Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release

May 28, 2025, 7:30 AM EDT - 4 months ago

Cencora Elects Lori J. Ryerkerk to Its Board of Directors

May 16, 2025, 8:37 AM EDT - 5 months ago

Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs

May 7, 2025, 2:06 PM EDT - 5 months ago

Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings

May 7, 2025, 10:55 AM EDT - 5 months ago

Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript

May 7, 2025, 6:30 AM EDT - 5 months ago

Cencora Reports Fiscal 2025 Second Quarter Results

Apr 4, 2025, 3:42 PM EDT - 6 months ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

CVS MCK PM

Mar 31, 2025, 7:35 AM EDT - 6 months ago

These 15 stocks are the most profitable companies in the S&P 500

AAPL ABBV AON BA CL CLX DVA

Mar 28, 2025, 7:00 AM EDT - 6 months ago

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Feb 26, 2025, 11:00 AM EST - 7 months ago

Cencora: Higher Potential Returns After Reduced Walgreens Stake

Feb 6, 2025, 8:37 PM EST - 8 months ago

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Feb 6, 2025, 8:30 PM EST - 8 months ago

Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds

WBA

Feb 6, 2025, 8:30 AM EST - 8 months ago

Cencora Reinforces Efforts to Strengthen Pharmaceutical Supply Chain with Expansion of Drug Shortages Mitigation Program

Feb 5, 2025, 11:40 AM EST - 8 months ago

Cencora (COR) Q1 2025 Earnings Call Transcript

Feb 5, 2025, 7:23 AM EST - 8 months ago

Cencora raises 2025 profit forecast on specialty drug demand

Feb 5, 2025, 6:30 AM EST - 8 months ago

Cencora Reports Fiscal 2025 First Quarter Results

Jan 27, 2025, 7:30 AM EST - 8 months ago

Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients

HROW

Jan 13, 2025, 12:07 PM EST - 9 months ago

Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth

COST DHR EL MSGS WST

Jan 8, 2025, 7:30 AM EST - 9 months ago

Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release

Jan 2, 2025, 4:23 PM EST - 9 months ago

Cencora raises annual profit forecast

Jan 2, 2025, 4:15 PM EST - 9 months ago

Cencora Completes Acquisition of Retina Consultants of America

Dec 9, 2024, 4:15 PM EST - 10 months ago

Cencora Closes $1.8 Billion Senior Notes Offering

Dec 6, 2024, 8:30 AM EST - 10 months ago

Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers

Dec 5, 2024, 10:26 AM EST - 10 months ago

Cencora: Competitive Advantages Defined

Dec 2, 2024, 10:49 PM EST - 10 months ago

Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035

Nov 26, 2024, 8:30 AM EST - 11 months ago

Cencora to Host Inaugural Product Showcase

Nov 6, 2024, 11:38 AM EST - 11 months ago

Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings

Nov 6, 2024, 10:56 AM EST - 11 months ago

Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript

Nov 6, 2024, 6:54 AM EST - 11 months ago

Cencora to buy Retina Consultants of America for $4.6 bln

Nov 6, 2024, 6:35 AM EST - 11 months ago

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

Nov 6, 2024, 6:30 AM EST - 11 months ago

Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America

Nov 4, 2024, 8:30 AM EST - 11 months ago

Cencora Expands Enterprise Leadership Team with Two Senior Appointments

Nov 1, 2024, 4:42 PM EDT - 1 year ago

Dividend Aristocrats Of The Future - Part 3

AIZ COST CSX DUK K RSG SRE

Oct 1, 2024, 7:30 AM EDT - 1 year ago

Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release

Sep 10, 2024, 8:30 AM EDT - 1 year ago

Cencora Supports Pharmaceutical Supply Chain Education with Two New Programs for Health System Pharmacy Residents

Aug 15, 2024, 7:30 AM EDT - 1 year ago

Cencora Elects Frank Clyburn to Its Board of Directors

Aug 14, 2024, 9:00 AM EDT - 1 year ago

Intelliguard, Cencora Partner to Increase Compatibility of RFID-Tagged Medications, Medication Management Systems

Aug 2, 2024, 1:59 PM EDT - 1 year ago

Walgreens continues to shed stake in Cencora as it looks to bolster turnaround

WBA

Aug 2, 2024, 10:45 AM EDT - 1 year ago

Pharma giant Cencora is alerting millions about its data breach

Aug 1, 2024, 6:20 PM EDT - 1 year ago

Walgreens further reduces stake in Cencora

WBA

Aug 1, 2024, 6:08 PM EDT - 1 year ago

Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds

WBA

SweepCastApp Oct. 3 at 3:43 PM

$COR: Unusual Options Activity Alerted CALL flow observed 13x contracts at Strike price of $310 Exp on 01/15/2027 with Premium of $59K and showing NEUTRAL Sentiment

0 · Reply

MoneyGroupLLC Oct. 3 at 1:11 AM

Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $9.20 - $9.80 Take Profit: $13.72 Stop Bleeding: $8.62 ROI Potential: 40% Exit Within: 227 Minutes https://moneygroup.us/alerts

0 · Reply

StockAutoPro Oct. 2 at 5:39 PM

$COR: Buy target $309.19 Sell target $326.74 Expect volatility in COR stocks due to increased competition in the cloud data storage market.

0 · Reply

MoneyGroupLLC Oct. 2 at 7:05 AM

Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $9.80 - $11.00 Take Profit: $23.42 Stop Bleeding: $8.62 ROI Potential: 139% Exit Within: 93 Minutes https://moneygroup.us/alerts

0 · Reply

SweepCastApp Oct. 2 at 5:51 AM

$COR: Unusual Options Activity Alerted CALL flow observed 10x contracts at Strike price of $220 Exp on 10/17/2025 with Premium of $88K and showing BEARISH Sentiment

0 · Reply

MoneyGroupLLC Oct. 1 at 12:05 PM

Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $8.85 - $10.40 Take Profit: $13.89 Stop Bleeding: $7.79 ROI Potential: 57% Exit Within: 365 Minutes https://moneygroup.us/alerts

0 · Reply

MoneyGroupLLC Sep. 30 at 11:43 PM

Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $7.00 - $9.20 Take Profit: $11.13 Stop Bleeding: $6.16 ROI Potential: 59% Exit Within: 372 Minutes https://moneygroup.us/alerts

0 · Reply

highnihilism Sep. 30 at 8:10 AM

0 · Reply

MoneyGroupLLC Sep. 29 at 11:22 PM

Enter: $COR NOV 21 2025 $310 CALLS Buy in Price: $11.05 - $11.60 Take Profit: $21.99 Stop Bleeding: $9.72 ROI Potential: 99% Exit Within: 268 Minutes https://moneygroup.us/alerts

0 · Reply

StockAutoPro Sep. 29 at 9:57 PM

$COR: Buy target $306.07 Sell target $323.47 Recent acquisitions are driving significant growth for this leading waste management company.

0 · Reply

DipSniper99s Sep. 28 at 3:06 PM

$COR OBV rising while price coils—accumulation fingerprints. $NXXT

0 · Reply

MoneyGroupLLC Sep. 28 at 1:26 PM

Enter: $COR NOV 21 2025 $310 CALLS Buy in Price: $11.05 - $12.00 Take Profit: $24.86 Stop Bleeding: $9.72 ROI Potential: 125% Exit Within: 97 Minutes https://moneygroup.us/alerts

0 · Reply

SweepCastApp Sep. 28 at 11:54 AM

$COR: Unusual Options Activity Alerted PUT flow observed 500x contracts at Strike price of $300 Exp on 10/17/2025 with Premium of $290K and showing BEARISH Sentiment

0 · Reply

MoneyGroupLLC Sep. 27 at 9:25 PM

Enter: $COR NOV 21 2025 $310 CALLS Buy in Price: $11.05 - $12.00 Take Profit: $24.86 Stop Bleeding: $9.72 ROI Potential: 125% Exit Within: 97 Minutes https://moneygroup.us/alerts

0 · Reply

StockAutoPro Sep. 26 at 9:26 PM

$COR: Buy target $305.0 Sell target $322.35 Strong quarterly earnings report suggests potential growth for this leading waste management company.

0 · Reply

MoneyGroupLLC Sep. 25 at 2:08 AM

Enter: $COR OCT 17 2025 $310 CALLS Buy in Price: $7.45 - $7.80 Take Profit: $16.09 Stop Bleeding: $6.56 ROI Potential: 116% Exit Within: 296 Minutes https://moneygroup.us/alerts

0 · Reply

notreload_ai Sep. 24 at 12:44 PM

Citi increased $MCK's price target to $860 from $820 and maintains a Buy rating after investor day. The firm views the company’s better than expected fiscal 2026 guidance raise as a "surprise." Drug distributor McKesson boosted its 2026 profit outlook Tuesday, citing strong momentum and efficient management. This positive news sent McKesson stock up about 6%, and rivals $COR and $CAH also saw gains of about 5%.

1 · Reply

MoneyGroupLLC Sep. 24 at 6:50 AM

Enter: $COR OCT 17 2025 $310 CALLS Buy in Price: $4.40 - $4.90 Take Profit: $9.90 Stop Bleeding: $3.87 ROI Potential: 125% Exit Within: 271 Minutes https://moneygroup.us/alerts

0 · Reply

Proteus63 Sep. 22 at 3:06 PM

$COR $MCK $CAH Got this Feb 2025 excerpt off of an Indian website (Prathamesh Enterprises); didn't post the link because I got a hit from my antivirus software off the site. Curious on how the ongoing Russian oil tariff issues, plus the new H-1B Visa fees, will impact the US-India Pharma industry connections and supply chains.

1 · Reply

LiquidThetaLEAPS Sep. 22 at 6:32 AM

0 · Reply

MoneyGroupLLC Sep. 22 at 12:27 AM

Enter: $COR OCT 17 2025 $300 CALLS Buy in Price: $4.16 - $4.60 Take Profit: $5.82 Stop Bleeding: $3.66 ROI Potential: 40% Exit Within: 375 Minutes https://moneygroup.us/alerts

0 · Reply

DebroahRushing280 Sep. 21 at 6:00 AM

$COR Healthcare REIT resilience. Interest rate headwinds priced in. Sector rotation beneficiary.

0 · Reply

Market Cap	59.82B
Revenue (ttm)	293.96B
Net Income (ttm)	1.51B
EPS (ttm)	N/A
PE Ratio	20.13
Forward PE	17.93
Profit Margin	0.51%
Debt to Equity Ratio	3.73

Volume	1,253,300
Avg Vol	1,514,550
Day's Range	N/A - N/A
Shares Out	193.88M
Stochastic %K	51%
Beta	0.63
Analysts	Strong Sell
Price Target	$336.50